M Tribalto

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials

Stefano Pasquali, J D Maqueo, Jorge Espino Vela et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1998 · 473 citations

Medicine, Oncology, Pharmacology +16

Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy

Franco Mandelli, Giuseppe Avvisati, Sergio Amadori et al. · New England Journal of Medicine · 1990 · 385 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia

Giovanni Del Poeta, Roberto Stasi, Germano Aronica et al. · Blood · 1996 · 127 citations · Full text

Medicine, Molecular Biology, Oncology +10

Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients.

Mario Boccadoro, Filippo Marmont, M Tribalto et al. · Journal of Clinical Oncology · 1991 · 124 citations

Medicine, Oncology, Pharmacology +13

Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia

Roberto Stasi, Giovanni Del Poeta, Mario Masi et al. · Cancer Genetics and Cytogenetics · 1993 · 89 citations

Life Sciences, Genetics, Hematology +16